Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Oil Prices Jump as U.S.-Iran Conflict and Strait of Hormuz Tensions Shake Global Markets 
Every generation thinks they had it the toughest, but for Gen Z, they’re probably right 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Paramount-Warner Bros. Discovery Merger Faces Lawsuit From 12 States 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that 
Booked to travel through the Middle East? Here’s why you shouldn’t cancel your flight 
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks 
How to support someone who is grieving: five research-backed strategies 
US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak 
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
Trump, Canada Reach Gordie Howe Bridge Deal Ahead of July 27 Opening 
Singapore GDP Grows 5.7% in Q2 2026 as AI-Driven Manufacturing Boosts Economy 
Bubs Australia will manufacture and distribute Bubs’ Chinese-label goat milk infant formula in China according to new Chinese standards. under an agreement with Heilongjiang Ubeite Dairy Group (HUG).
The new standards will come into effect in February 2023 .
The “ultra-premium” infant formula has been specially developed for Chinese infants using easily-digestible A2 goat-milk protein, sn2 palmitate (OPO), lactoferrin prebiotics, and nucleotides.
HUG has started submission with the State Administration for Market Regulation (SAMR) to renew its registration in line with China’s new GB standards for exclusive use under the Bubs brand.
According to Kristy Carr, Bubs founder and CEO, they have built strong brand trust and loyalty with Chinese families through marketing and selling Bubs English label infant formula products via the crossborder eCommerce channel, which accounts for around 20 percent of total Chinese infant formula sales.
If approved by SAMR, the formula will give Bubs access to the remaining 80 percent of China’s $25.9 billion infant formula market.
Bubs will also enter into a joint venture agreement, where it will hold a 75 percent interest, with Zhitong Health Technology to distribute its Chinese label goat infant formula products.
Bubs Australia expects to launch its product in the second half of FY23, subject to receiving SAMR approval.
